oral, brain-penetrant O-GlcNAcase (OGA) inh. structurally distinct in vivo tool from virtual screen of 100k cmpd, testing 2681 J. Med. Chem., Jan. 6, 2021 Takeda Pharmaceutical, Fujisawa, JP